145 related articles for article (PubMed ID: 20724141)
21. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
22. Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer.
Aloysius MM; Zaitoun AM; Awad S; Ilyas M; Rowlands BJ; Lobo DN
Br J Surg; 2010 Aug; 97(8):1269-78. PubMed ID: 20602499
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
[TBL] [Abstract][Full Text] [Related]
24. Reappraisal of a method of reconstruction after pancreatoduodenectomy.
Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
Hepatogastroenterology; 2005; 52(64):1077-82. PubMed ID: 16001633
[TBL] [Abstract][Full Text] [Related]
25. Partial duodenopancreatectomy with radical lymphadenectomy in patients with pancreatic and periampullary carcinomas: initial results.
Henne-Bruns D; Kremer B; Meyer-Pannwitt U; Vogel I; Schröder S
Hepatogastroenterology; 1993 Apr; 40(2):145-9. PubMed ID: 8099561
[TBL] [Abstract][Full Text] [Related]
26. Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy?
Park SJ; Kim SW; Jang JY; Lee KU; Park YH
World J Surg; 2002 Apr; 26(4):487-92. PubMed ID: 11910485
[TBL] [Abstract][Full Text] [Related]
27. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
Schwarz RE; Keny H
Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of 67 pancreatic head tumors and 27 periampullary tumors].
Nobili P; Annolfi B; Crosta C; Dassi FL; Porretta T; Rovati M
Ann Ital Chir; 1993; 64(5):505-11. PubMed ID: 7912055
[TBL] [Abstract][Full Text] [Related]
29. An audit of outcomes of a series of periampullary carcinomas.
Berberat PO; Künzli BM; Gulbinas A; Ramanauskas T; Kleeff J; Müller MW; Wagner M; Friess H; Büchler MW
Eur J Surg Oncol; 2009 Feb; 35(2):187-91. PubMed ID: 18343082
[TBL] [Abstract][Full Text] [Related]
30. DNA analysis of periampullary cancers.
Katagiri H; Okayasu I; Endo M
Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):1-18. PubMed ID: 2225281
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic factors in pancreatic cancer].
Höfler H
Chirurg; 1994 Apr; 65(4):253-7. PubMed ID: 8020344
[TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of 150 cases with periampullary carcinoma].
Wu XD
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):296-9. PubMed ID: 7909747
[TBL] [Abstract][Full Text] [Related]
33. [Clinical symptoms in cancer of the exocrine pancreas in peri-ampullary region. Old and new knowledge from the analysis of a surgical patient sample].
Ridder GJ; Klempnauer J
Zentralbl Chir; 1996; 121(7):557-64. PubMed ID: 8967195
[TBL] [Abstract][Full Text] [Related]
34. [The curative surgery of periampullary tumors. The results of 48 resections].
de Almeida JC; Bettencourt A; Costa CS; de Almeida JM
Acta Med Port; 1995 Jun; 8 Suppl 1():S35-9. PubMed ID: 7653304
[TBL] [Abstract][Full Text] [Related]
35. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
[TBL] [Abstract][Full Text] [Related]
36. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
Sellner FJ; Riegler FM; Machacek E
Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
[TBL] [Abstract][Full Text] [Related]
37. [Cancer of the pancreatic head and the periampullary region].
Bjørnland K; Ofstad E; Hognestad J
Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2983-5. PubMed ID: 2237846
[TBL] [Abstract][Full Text] [Related]
38. Comparison of resectable and unresectable periampullary carcinomas.
Shyr YM; Su CH; Wang HC; Lo SS; Lui WY
J Am Coll Surg; 1994 Apr; 178(4):369-78. PubMed ID: 7511967
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.
Vaidya P; Kawarada Y; Higashiguchi T; Yoshida T; Sakakura T; Yatani R
J Pathol; 1996 Feb; 178(2):140-5. PubMed ID: 8683379
[TBL] [Abstract][Full Text] [Related]
40. Survivin expression and its clinical significance in pancreatic cancer.
Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
